
Sign up to save your podcasts
Or


Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Barclays traders struggled to capitalize on a volatile quarter with returns falling short of their US rivals.
- Novartis’s profit fell more than estimated and sales unexpectedly declined in the first quarter as some of the drugmaker’s best-selling medicines were hit hard by generic competition.
- WPP reported an organic sales decline of 6.7% in 1Q, higher than more pessimistic analyst forecasts.
See omnystudio.com/listener for privacy information.
By iHeartPodcasts4.6
1919 ratings
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Barclays traders struggled to capitalize on a volatile quarter with returns falling short of their US rivals.
- Novartis’s profit fell more than estimated and sales unexpectedly declined in the first quarter as some of the drugmaker’s best-selling medicines were hit hard by generic competition.
- WPP reported an organic sales decline of 6.7% in 1Q, higher than more pessimistic analyst forecasts.
See omnystudio.com/listener for privacy information.

405 Listeners

1,167 Listeners

2,190 Listeners

1,982 Listeners

420 Listeners

1,037 Listeners

1,307 Listeners

62 Listeners

59 Listeners

154 Listeners

83 Listeners

76 Listeners

76 Listeners

8 Listeners

11 Listeners